DEEJ(SZ:000423)2026-03-19 12:50Financial Performance - In 2025, the company achieved operating revenue of CNY 6.70 billion, an increase of 13.17% compared to the previous year[22]. - The net profit attributable to shareholders reached CNY 1.74 billion, reflecting an 11.67% year-on-year growth[22]. - The net cash flow from operating activities was CNY 2.29 billion, up 5.45% from the previous year[22]. - Basic earnings per share were CNY 2.70, representing an increase of 11.57% compared to CNY 2.42 in 2024[22]. - The total assets of the company at the end of 2025 amounted to CNY 13.38 billion, a 2.25% increase from the previous year[22]. - The net profit after deducting non-recurring gains and losses was CNY 1.64 billion, a 13.62% increase year-on-year[22]. - The company reported a non-current asset disposal gain of approximately ¥13.20 million, a significant increase from a loss of ¥1.39 million in 2024 and a gain of ¥11.00 million in 2023[28]. - The company's operating revenue for Q4 2023 reached approximately ¥1.93 billion, showing a growth compared to Q3 2023's ¥1.72 billion[29]. - The net profit attributable to shareholders for Q4 2023 was approximately ¥464.92 million, up from ¥456.10 million in Q3 2023[29]. - The net cash flow from operating activities in Q2 2023 was approximately ¥1.27 billion, a recovery from a negative cash flow of approximately ¥304.13 million in Q1 2023[29]. Strategic Acquisitions and Expansion - The company acquired 100% equity of Dong-E-E-Jiao International (BVI) Co., Ltd. in July 2025 to enhance its overseas business development[23]. - The company acquired 80% of Inner Mongolia Alashan Cangrong Group and 100% of Dong'e Ejiao International (BVI) Co., Ltd., expanding its business scope[56]. - The company has established a presence in over 10 countries and regions, including Southeast Asia, Japan, South Korea, and Europe, to expand its international market reach[48]. - The company plans to enhance its raw material assurance system through strategic procurement and technological empowerment[81]. - The company is committed to expanding its product offerings, particularly in male health supplements, and exploring strategic acquisitions to enhance its market position[84]. Product Development and Innovation - The company plans to launch new low-sugar and rose-flavored Ejiao cakes in 2025, expanding its product line to cater to health-conscious consumers[32]. - The company is focusing on the male health supplement market with products like "Royal Weichang 1619" and "Zhuangben," targeting a new growth curve[33]. - The company is expanding its product line, including the development of health products like "Xiaojintiao" instant Aojiao powder and various health supplements targeting men's health[46]. - The company is conducting 30 clinical research projects for 复方阿胶浆, aiming to expand its therapeutic applications[61]. - The company is advancing 13 projects in livestock breeding technology to modernize and standardize the donkey industry[62]. Research and Development - Research and development expenses rose by 56.80% to ¥272,449,725.79, reflecting increased investment in key projects[60]. - R&D investment increased by 60.61% to ¥337,196,812.70 in 2025, representing 5.03% of operating revenue, up by 1.62 percentage points from the previous year[63]. - The number of R&D personnel rose to 341, with a 0.89% increase, while the proportion of R&D personnel to total staff decreased by 0.40 percentage points to 7.85%[63]. - The company has over 40 strategic reserve products in development, indicating a strong pipeline for future growth[36]. Quality Control and Compliance - The company maintained a 100% pass rate for market sampling inspections and external supervision audits, with zero quality incidents reported[41]. - The company led or participated in the formulation of 11 national/industry/group standards in 2025, enhancing the quality control framework for its products[42]. - The company has implemented a "Quality and Return Dual Improvement" action plan to enhance operational quality and shareholder returns[89]. - The company strictly adheres to relevant laws and regulations, enhancing information disclosure management to ensure timely and accurate information for investors[95]. Governance and Management - The company has optimized its governance structure, ensuring compliance with legal requirements and enhancing operational independence from its controlling shareholder[91]. - The company has established a reasonable mechanism for selecting its management team, ensuring clear division of responsibilities among executives[95]. - The board of directors and senior management are structured according to the company's articles of association, ensuring proper governance[98]. - The company has implemented a stock incentive plan, granting shares to key executives to align their interests with those of shareholders[100]. - The company has a structured board with independent directors, ensuring oversight and governance in line with regulatory requirements[100]. Employee Development and Compensation - The total number of employees at the end of the reporting period is 4,345, with 2,462 from the parent company and 1,883 from major subsidiaries[125]. - The company has implemented a systematic salary management system to attract and retain top talent, optimizing salary ranges based on internal and external benchmarks[126]. - The company has focused on building a talent pipeline through various training programs, including leadership training for young cadres and project management training for R&D staff[128]. - The total compensation for directors and senior management during the reporting period amounted to CNY 1,244.26 million[115]. - The performance assessment for the compensation of directors and senior management is based on the company's performance management methods[116]. Financial Management and Risks - The company faces long-term risks related to rising raw material costs, particularly for donkey hides, which are crucial for its products[80]. - The company has no significant litigation or arbitration matters during the reporting period[161]. - The company has no major related party transactions during the reporting period[164]. - The company has entrusted financial institutions with asset management, with a total balance of RMB 990 million in low-risk bank wealth management products and RMB 2.81 billion in medium-low-risk products, with no overdue amounts[176]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 87,763, an increase from 67,572 at the end of the previous month[191]. - The largest shareholder, China Resources Dong'e Ejiao Co., Ltd., holds 23.50% of the shares, totaling 151,351,731 shares[192]. - The total shares held by the top 10 shareholders account for 33.70% of the company's total share capital[192]. - The company has a share repurchase plan with a maximum amount of CNY 20 billion, targeting to repurchase approximately 1.38 million shares at a price not exceeding CNY 72.08 per share[200].